Ratings by Wells Fargo (Eva Verdejo)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/8/2026 | Zymeworks | ZYME | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/12/2025 | Zymeworks | ZYME | Upgrade | Overweight (Equal Weight) |
24.94 (23.14) |
-7.22% | Details | |
| 11/19/2025 | Zymeworks | ZYME | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/24/2025 | Zymeworks | ZYME | New Coverage | Equal Weight (N/A) |
17.67 (24.94) |
41.14% | Details | |
| 4/17/2025 | Bicara Therapeutics | BCAX | New Coverage | Underweight (N/A) |
7.22 (23.23) |
221.75% | Details |
